Mission: Craig’s Cause Pancreatic Cancer Society is a national charity dedicated to both increasing survival and improving the quality of life for every Canadian diagnosed with pancreatic cancer through awareness raising, education, support and research.
Vision: “A world where surviving pancreatic cancer is expected”.
In June 2006, Craig Schurman Condon, started to feel unwell, experiencing acid reflux, white stool, dark urine and yellowish skin. Concerned, he visited his physician. His physician suspected Hepatitis A. When this came back negative, his physician was stumped. This is where Craig’s pancreatic cancer journey began.
In July 2006, Craig was diagnosed with pancreatic cancer. By September, he had passed away, at the age of 63, eight weeks from diagnosis.
In 2007, ‘Craig’s Cause’ was established as a non profit organization, in his memory. The goal was to create awareness and to fund research. In 2012 ‘Craig’s Cause Pancreatic Cancer Society’ was rebranded and received its national charitable business number.
Since its inception, this grassroots organization has grown into a national charity recognized for our national awareness campaigns and events, our education and support programs and for our support of a diversified research portfolio.
We are proud of our collaboration with international, national and provincial boards, health care organizations, facilities and professionals, and a variety of other cancer organizations and research institutes. These partnerships and fundraising efforts have raised over $2,000,000 in research funding alone.
Lastly, Craig’s Cause Pancreatic Cancer Society has distinguished itself from so many other charitable organizations by maintaining our mission to donate 100% of all charitable donations to awareness, education, patient support and research programs.
The activities of the organization are overseen by a Board of Directors. The Chair of the Board of Directors role is to ensure that the board is effective in implementing the organization’s strategic plan.
Implementation of the strategic plan and the activities of the organization are delivered by the organization’s staff and volunteers under the direction and supervision of the Executive Director. The Executive Director will report to the Chair.
As the governing body of Craig’s Cause Pancreatic Cancer Society, the Board of Directors is responsible for ensuring that the Society operates in accordance with its by-laws and the Not-For-Profit Corporations Act and its regulations, the articles and any unanimous member agreement.
The Board’s activities are determined by the powers, duties and responsibilities delegated to it by the organization’s bylaws and strategic operating plan.
Craig's Cause Pancreatic Cancer Society's Medical Advisory Committee provides significant contribution to several of our programs.
Our Medical Advisory Committee has professionals from several healthcare disciplines, providing us with a variety of informed perspectives. Their critical contributions provide Craig's Cause Pancreatic Cancer Society with:
- informative recommendations regarding medical based questions, supporting our Ask a Doctor Program.
-an advisory role in determining and securing a diverse portfolio of research projects across Canada.
- planning and development recommendations for our Eastern Canada Pancreatic Cancer Symposium and our Pancreas Summit.
- the writing and development of educational materials and tools for both the healthcare sector and general public
– the participation in local, provincial and national meetings, representing Craig's Cause Pancreatic Cancer Society.
Dr. Ramjeesingh, moved to Halifax in 2015, having originally completed his MD/Ph.D in Toronto before completing residency and medical oncology training in Kingston, ON. Dr. Ramjeesingh has focused his clinical practice on the treatment of breast cancer and hepatopancreobiliary (HPB) tumors which includes pancreatic cancer. His research activities and interests are in the fields of Health service delivery, and translational research in Oncology. He has a passion for oncology
education of residents and medical students, having become a faulty member foroncologyeducation.com.
He has been awarded the Department of Medicine Research Excellent award in 2017 and the DOM Excellence in Medical Education award in 2018. Why for Pancreatic Cancer Involvement: Nova Scotia has historically had some of the poorest outcomes for survival of pancreatic cancer. When he moved to Nova Scotia, no one could answer his questions about why survival was so poor when compared to other provinces. He began to notice gaps in the process of diagnosing and treating pancreatic cancer and felt the need to take up this cause; to improve where he can for pancreatic cancer patients in the province.
Dr. Colwell is an Associate Professor of Medicine at Dalhousie University. He has been involved in clinical research that has led to several publications including the New England Journal of Medicine. He is a member of the GI, Breast and sarcoma tumor site groups. He is Chair of the Gastrointestinal Tumor Site Group. He is President of the Canadian Association of Medical Oncology Committee, (CAMO). He is a member of NSHA Drugs and Therapeutics Committee and chair the Oncology Therapeutics Subcommittee for that same group. He has an interest in Biosimilars, GI, and breast cancers, and resident education.
Melanie was a graduate of the Dalhousie Pharmacy Program in 2015 and she recently completed her Hospital Pharmacy Residency through Dalhousie College of Pharmacy at The Moncton Hospital.
Melanie is a dedicated individual with a passion for excellent patient care. She enjoys educating patients on their medication, promoting patient education.
Dr. Urquhart’s primary research interests relate to understanding and optimizing the movement of evidence-based innovations into clinical practice as well as the interface between evidence-based medicine and policy.
Robin uses multiple methods in her research, including linked administrative health data, systematic reviews, and case study and qualitative methods.
The ultimate aim of her work is to improve our ability to implement and sustain innovations that improve the organization, delivery, and outcomes of cancer care.
Dr. Boudreau investigates how human natural killer cell immunogenetics program immune responsiveness to cancer and infectious diseases. She uses bioinformatics, humanized in vivo models, cell-signal analysis, and highly-parametric flow cytometry to understand how genetic variation creates diversity in human immune potentials.
Her interdisciplinary and collaborative work aims to translate research findings into precision therapies.
Dr. Mark Walsh is a surgeon in the General Surgery department at the QEII Health Sciences Centre. He is a Hepatobiliary / Pancreatic / Transplant Surgeon with a passion to treat and support patients diagnosed with pancreatic cancer.
Dr. Michele Molinari is a Hepatobiliary / Pancreatic / Transplant Surgeon with a passion to treat and support patients diagnosed with pancreatic cancer.
Michele’s research interests include; Clinical Epidemiology of Hepatobiliary and Pancreatic Diseases, Liver Transplantation Outcome Research, Clinical Decision Making
Adam Nelson is a PhD. candidate in Dr. Brent Johnston’s lab at Dalhousie University. His research focuses on new combination therapies for pancreatic cancer using immunotherapy and oncolytic viruses, viruses that only target cancer cells. He hopes that his combination therapy will provide a safe and effective alternative therapy for patients suffering from pancreatic cancer.
Jessica is a PhD candidate in the Chemistry Department at Dalhousie University where her research focuses on optimizing front-end sample preparation strategies for proteome analysis by mass spectrometry. She was inspired to get involved with Craig’s Cause after participating in the 2019 Walk/Bike/Run awareness event. Jessica now helps facilitate monthly online Support4Caregivers meetings and is gaining involvement with the Clinical Trial Finder program.
Jessica saw the untimely passing of her two uncles, Doug and Jim from pancreatic cancer, but never imagined it would hit any closer to home. In the Fall of 2018, her Dad was diagnosed with stage IV. She and her family were incredibly fortunate to share the following year together, but Greg lost his hard-fought battle in the Fall of 2019. All three of these patients were victims of the late diagnosis that is often associated with pancreatic cancer, which motivates Jessica to contribute to the awareness and supportive efforts of Craig’s Cause in hopes of improving the outcomes for pancreatic cancer patients in the future.
Our team at Craig's Cause Pancreatic Cancer Society is small but mighty with a national reach. We are committed to improving pancreatic cancer patient outcomes and quality of life. We are committed to working tirelessly to ensure our programs support this goal.
We believe in fostering an environment of collaboration and community which brings the right people together, who are willing to support us as we forge new paths, to meet today's challenges. Our team perseveres to make change. Most importantly, we serve our community with compassion and empathy, understanding that each pancreatic cancer experience is unique.
Stefanie Condon-Oldreive presently resides in Porters Lake, Nova Scotia. She is an elementary school teacher with the Halifax Regional Municipality since 2001 and Founder and Executive Director of Craig’s Cause Pancreatic Cancer Society since 2006.
Stefanie has been nominated for the Teacher Excellence Award twice with HRSB and she has been recognized for her work with Craig’s Cause Pancreatic Cancer Society by “A Toast to the Work of Women,” The HalifaxRegional Municipality, by the Speaker of the House, the Honorable Mr. Kevin Murphy and The Maritime Philanthropic Awards. Lastly, she received a RICCOH coaching award for her work as coach of a novice skip team on the Eastern Shore.
At Craig’s Cause Pancreatic Cancer Society, Stefanie serves as the Founder and Director. She has “her hand in” all areas of the running of the organization and heads the Pancreatic Cancer Awareness Walk/Run/Bike in Nova Scotia. Stefanie is excited about the next three years at Craig's Cause Pancreatic Cancer Society. The unveiling of our new brand, the welcoming of new board members, the introduction to new programs and the formation of new partnerships demonstrates how a community can be brought together to help defeat pancreatic cancer.
“Losing my father to pancreatic cancer, so suddenly, was devastating. What was even more frustrating was the lack of information and awareness available to Canadians. After dad’s passing I promised myself that others would not feel the isolation that we did from support and knowledge about this disease.”
Kate spent almost 15 years in the healthcare field before moving to the non-profit sector. She volunteered with Craig’s Cause Pancreatic Cancer Society for several years and was welcomed as their first employee in 2015.
Kate’s role includes managing the public facing programs such as Awareness Events, Patient Financial Grant Program, Ask a Doctor program, Tax Receipts and Acknowledgements, the toll free support line, general emails,website inquiries, social media, monthly newsletter and print material. In addition, she assists with corporate sponsorships, grant requests and general fundraising initiatives.
She is inspired by the stories of those impacted by pancreatic cancer and those working hard everyday to improve pancreatic cancer outcomes.
Jenna originally joined the Craig’s Cause team as a summer student in2018. After completing her undergraduate degree, she moved to the UK for a year. Whehe eturned home in 2019 to complete her MSc part-time, we welcomed her back as aprogram co-ordinator for both the Support4Caregivers and Healthcare Outreach Programs.In hat time she has worked to organise, promote and facilitate a monthly webinar andonline support group for the Support4Caregivers program. Within the Healthcare outreachprogram, she worked to contact medical and nursing schools across the country to bettereducate doctors and nurses on the symptoms, diagnosis and management of pancreaticcancer. This has culminated in our upcoming E-Learning Module for healthcareprofessionals.
In May 2008, Jenna’s grandfather, Fred Mounce, was diagnosed with pancreatic cancer. A mere six days later, he lost his life. She often hears stories about the incredible man that he was, though she remembers him as the “Freddie” who loved and spoiled her,and taught her that she was capable of anything she set her mind to. The timeline of his pancreatic cancer journey remains shocking to Jenna, as do the facts & statistics she
continues to learn about pancreatic
Helen came to Craig’s Cause Pancreatic Cancer Society in the fall of 2020 from the Arts Admin side of the non-profit world. Specializing in communications, events, marketing and operations, she has over twenty years experience doing whatever needs to be done to make the charity run smoothly.
Like many, before working for us, Helen knew very little about pancreatic cancer. Now, she is motivated to spread the word and make sure everyone knows of this disease. From risks & symptoms, to what to discuss with your doctor, to how you can help and everything in between.
Craig's Cause Pancreatic Cancer Society believes that by bringing the right people together, we will increase survival rates and improve the quality of life for all Canadians diagnosed.
Businesses and industry partners are key to us achieving these goals. Through unrestricted educational grants, corporate support and collaborations we know that we will eventually defeat pancreatic cancer.
We appreciate your continued support!
For all press inquiries contact
Founder / Director
For general inquires email email@example.com or call 1-877-212-9582
October 25, 2020
New Brunswick’s annual walk for pancreatic cancer goes virtual
November 17, 2020
Group advocating for pancreatic cancer drug to be used in Canada
November 19th, 2020
Founder talks World Pancreatic Cancer Day
February 10th, 2021
Delayed Pancreatic Cancer Diagnoses Mean Less Time With Loved Ones